Abstract
Peritonitis is a major complication of intermittent peritoneal dialysis (IPD); over 70% of the infections are caused by Gram-positive bacteria. Vancomycin (V) is the antibiotic of choice in the treatment of peritonitis caused by G(+). The influence of vancomycin on peritoneal transport in IPD patients has not been described before. We have investigated the effect of intraperitoneal vancomycin on dialysis efficiency in 8 IPD patients using dialysis solutions containing either lactate or acetate. The following parameters were measured: net ultrafiltration (UF), concentration ratios (D/P) of urea, creatinine, potassium, peritoneal clearances (ml/min) of urea, creatinine, potassium, mass transfer of sodium (MTNa), sodium sieving index (SCNa). It has been found that vancomycin significantly decreases D/P urea (p<0.05) and creatinine (p<0.05). We found also a significant decrease of mean clearance of urea (p<0.05) and creatinine (p<0.05). The mean clearance of potassium did not change significantly. There was no significant change in UF, MTNa, and SCNa. Our preliminary data suggest that vancomycin decreases the permeability of peritoneum for certain low molecules in IPD patients which may have a negative impact on dialysis efficiency.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Vas, S. I.: Peritonitis. In: K. D.: Nolph (ed.): Peritoneal Dialysis: Kluwer Academic Publishers, Boston 1988, pp. 261–288.
Gokal, R., Francis, D. M. A., Goodship, T. H. J., Bint, A. J., Ramos, J. M., Ferner, R. E., Proud, G., Ward, M. K., Kerr, D. N. S.: Peritonitis in continuous ambulatory peritoneal dialysis.Lancet, II, 1388 (1982).
Keane, W. F., Everett, E. D., Golper, T. A., Gokal, R., Halstenson, C., Kawaguchi, Y., Riella, M., Vas, S. I., Verbrugh, H.: Peritoneal dialysis—Related peritonitis treatment recommendations 1993 update.Perit. Dial. Int., 13, 14 (1993).
Kim, D., Tapson, J., Wu, G., Khanna, R., Vas, S. I., Oreopoulos, D. G.: Staphylococcus aureus peritonitis in patients on continuous ambulatory peritoneal dialysis.Trans. Am. Soc. Artif. Int. Organs, 30, 494 (1984).
Ludlam, H. A., Price, T. N. C., Berry, A. J., Phillips, J.: Laboratory diagnosis of peritonitis in patients on continuous peritoneal dialysis.J. Clin. Microbiol., 26, 1757 (1988).
Piriano, B., Bernardini, J., Sorkin, M.: A five-year study of the microbiologic results of exit-site infections and peritonitis in continuous ambulatory peritoneal dialysis.Am. J. kidney Dis., 10, 281 (1987).
Maher, J. F., Hirszel, P., lasrich, M.: An experimental model for study of pharmacologic and hormonal influences on peritoneal dialysis.Contr. Nephrol., 17, 131 (1979).
Janicka, L., Majdan, M., Solski, J., Baranowska, E.: Changes in peritoneal transport following the use of intraperitoneal gentamicin.Perti. Dial. Int., 14, 168 (1994).
Breborowicz, A., Knapowski, J.: Hypertonicity changes the permeability of the mesothelium.Perit. Dial. Bull., 4, 167 (1984).
Digenis, G. E.: Anatomy of the peritoneal membrane.Perit. Dial. Bull., 4, 63 (1984).
Gotloib, L., Shustack, A.: Ultrastructural morphology of the peritoneum. New findings and speculations on transfer solutes and water during peritoneal dialysis.Perit. Dial. Bull., 7, 119 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Janicka, L., Książek, A., Solski, J. et al. Influence of intraperitoneal vancomycin on peritoneal dialysis efficiency. A clinical study. International Urology and Nephrology 29, 385–389 (1997). https://doi.org/10.1007/BF02550940
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02550940